Schedule 13D ownership disclosure

VERONA PHARMA PLC

Ordinary Shares, nominal value 0.05 GBP · CUSIP: 925050106

Event date: 2025-01-16

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Growth Equity Opportunities 17, LLCReported CIK 0001790256

    Shares: 32,678,025.00 · Class: 4.99%

  • New Enterprise Associates 17, L.P.Reported CIK 0001768564

    Shares: 32,678,025.00 · Class: 4.99%

  • NEA Partners 17, L.P.Reported CIK 0001796820

    Shares: 32,678,025.00 · Class: 4.99%

  • NEA 17 GP, LLCReported CIK 0001796821

    Shares: 32,678,025.00 · Class: 4.99%

  • Growth Equity Opportunities Fund IV, LLCReported CIK 0001644965

    Shares: 32,678,025.00 · Class: 4.99%

  • New Enterprise Associates 15, L.P.Reported CIK 0001629794

    Shares: 32,678,025.00 · Class: 4.99%

  • NEA Partners 15, L.P.Reported CIK 0001640031

    Shares: 32,678,025.00 · Class: 4.99%

  • NEA 15 GP, LLCReported CIK 0001640033

    Shares: 32,678,025.00 · Class: 4.99%

  • Forest BaskettReported CIK 0001277631

    Shares: 32,678,025.00 · Class: 4.99%

  • Ali BehbahaniReported CIK 0001613867

    Shares: 25,541,720.00 · Class: 3.90%

  • Carmen ChangReported CIK 0001746342

    Shares: 25,541,648.00 · Class: 3.90%

  • Anthony A. Florence, Jr.Reported CIK 0001559827

    Shares: 32,678,025.00 · Class: 4.99%

  • Mohamad H. MakhzoumiReported CIK 0001630226

    Shares: 32,678,393.00 · Class: 4.99%

  • Edward T. MathersReported CIK 0001328625

    Shares: 25,541,720.00 · Class: 3.90%

  • Scott D. SandellReported CIK 0001237289

    Shares: 32,679,649.00 · Class: 4.99%

  • Paul WalkerReported CIK 0001553150

    Shares: 25,541,720.00 · Class: 3.90%

  • Rick YangReported CIK 0001851328

    Shares: 25,541,584.00 · Class: 3.90%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001072613-25-000057
Form type
SCHEDULE 13D/A
Filer
Growth Equity Opportunities Fund IV, LLC
CIK
CIK 1644965
Filed
Jan 21, 2025
Reporting period
Jan 16, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub